Brain Cancer RTOG 1122

March 13, 2013

Location: The Hospital of Central Connecticut

Phase II Double-Blinded Placebo-Controlled Study of Bevacizumab With or Without AMG 386 in Patients With Recurrent Glioblastoma or Gliosarcoma.